GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/ERCP Complications

ERCP Complications

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated May 1, 2025

Quick Answer

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a critical therapeutic procedure for managing pancreaticobiliary diseases, but it is associated with significant risks. Below is a detailed overview of ERCP complications, including their incidence, risk factors, prevention strategies, and management: --- ### **1.


Endoscopic Retrograde Cholangiopancreatography (ERCP) is a critical therapeutic procedure for managing pancreaticobiliary diseases, but it is associated with significant risks. Below is a detailed overview of ERCP complications, including their incidence, risk factors, prevention strategies, and management:

---

### **1. Post-ERCP Pancreatitis (PEP):**

  • **Incidence:**
  • Occurs in ~5% of unselected patients.
  • Increases to ~15% in high-risk patients.
  • Severe PEP occurs in <1% of cases but can result in significant morbidity and occasional mortality.
  • **Risk Factors:**
  • Repeated cannulation attempts.
  • Pancreatic duct injection.
  • Sphincter of Oddi dysfunction.
  • Female sex, younger age, and history of recurrent pancreatitis.
  • **Prevention:**
  • Universal prophylaxis with rectal NSAIDs (indomethacin or diclofenac), reducing the risk by 50%.
  • Aggressive intravenous hydration with lactated Ringer’s solution due to its anti-inflammatory and microcirculatory benefits.
  • Prophylactic pancreatic stent placement (PSP) in high-risk patients, particularly when combined with NSAIDs.
  • Technical measures such as guidewire-assisted cannulation, early transition to precut sphincterotomy, and avoiding aggressive pancreatic duct contrast injection.

---

### **2. Bleeding (Postsphincterotomy Bleeding):**

  • **Incidence:**
  • Occurs in 1–2% of ERCP procedures, primarily after sphincterotomy.
  • **Risk Factors:**
  • Cholangitis, anticoagulation, thrombocytopenia, and chronic renal disease.
  • **Prevention and Management:**
  • Proper management of anticoagulants before and after ERCP.
  • Intraprocedural bleeding can often be controlled with epinephrine injection or balloon tamponade.
  • Persistent bleeding may require endoscopic therapy using clips, thermal probes, or fully covered self-expanding metal stents (fcSEMS).

---

### **3. Perforation:**

  • **Incidence:**
  • Rare, occurring in 0.1–0.6% of cases.
  • Can result from sphincterotomy, dilation, or guidewire trauma.
  • **Management:**
  • Early recognition during the procedure is critical.
  • Small or retroperitoneal perforations can often be managed endoscopically using clips, sutures, or stents.
  • Larger or delayed perforations may require surgical repair or drainage, particularly if associated with peritonitis or systemic infection.

---

### **4. Infection:**

  • **Types:**
  • **Cholangitis:** The most common infectious complication, occurring in 0.5–3% of cases.
  • **Cholecystitis:** Can occur days after ERCP, especially following metallic stent placement.
  • **Risk Factors:**
  • Incomplete biliary drainage.
  • Hilar obstruction.
  • Contaminated duodenoscopes.
  • **Prevention:**
  • Prophylactic antibiotics in high-risk situations (e.g., hilar obstruction or incomplete drainage).
  • Use of single-use or fully sterilizable duodenoscopes to reduce duodenoscope-associated infections.
  • **Management:**
  • Cholangitis: Antibiotics and ensuring adequate biliary drainage.
  • Cholecystitis: Managed with antibiotics and drainage (endoscopic or percutaneous) depending on patient stability.

---

### **5. Duodenoscope-Associated Infections:**

  • **Cause:**
  • Contamination of duodenoscopes despite reprocessing efforts.
  • **Prevention:**
  • Transition to single-use or fully sterilizable duodenoscopes.
  • Enhanced reprocessing protocols.

---

### **6. Other Complications:**

  • **Aspiration Pneumonia:** Rare but possible if patients aspirate during the procedure.
  • **Cardiopulmonary Complications:** Related to sedation or underlying patient comorbidities.

---

### **Strategies to Minimize ERCP Complications:**

1. **Proper Patient Selection:**

  • Avoid diagnostic ERCP when less invasive alternatives like Endoscopic Ultrasound (EUS) or Magnetic Resonance Cholangiopancreatography (MRCP) are available.
  • Reserve ERCP for therapeutic interventions.

2. **Technical Expertise:**

  • High-volume endoscopists and centers achieve better outcomes and fewer complications.
  • Centralization of ERCP to specialized units is recommended.

3. **Training and Quality Assurance:**

  • Use of simulation training, coaching, and report cards to improve operator skill.
  • Structured debriefing and mentorship programs to address the psychological impact of complications on endoscopists (second victim syndrome).

4. **Early Recognition and Multidisciplinary Management:**

  • Prompt identification of complications with early CT imaging when perforation or infection is suspected.
  • Collaboration between gastroenterology, surgery, and radiology teams for optimal rescue management.

5. **Emerging Technologies:**

  • AI-assisted quality monitoring and augmented reality simulators to improve procedural safety.
  • Digital endoscopy reporting platforms to standardize complication prevention protocols.

---

### **Conclusion:**

While ERCP carries significant risks, advancements in prophylactic strategies, technical refinement, and endoscopic rescue methods have greatly reduced morbidity and mortality. Prevention, early recognition, and expert management of complications are critical to improving patient outcomes.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer